Skip to main content
# Title Type of news Date Link of news
143 Safety Signal of Sitagliptin and the Risk of Fatigue Signal
142 Safety Signal of Lactulose and the Risk of Pruritus Signal
141 Safety Signal of Folic acid and the Risk of Constipation Signal
140 Safety Signal of Zoster Vaccine and the Risk of Pemphigoid Signal
139 Safety Signal of Zoster Vaccine and the Risk of Erythema multiforme Signal
138 Safety Signal of Zoster Vaccine and the Risk of Rash Pustular Signal
137 Safety Signal of Atezolizumab and the Risk of Sclerosing Cholangitis Signal
136 Safety Signal of Dabrafenib and the Risk of Disseminated Intravascular Coagulopathy (DIC) Signal
135 Safety Signal of Erenumab and the Risk of Raynaud’s Phenomenon Signal
134 Safety Signal of Isotretinoin and the Risk of Blood Growth Hormone Decrease (BGHD) Signal
Displaying 51 - 60 of 195